Hypothalamic antihypertensive effect of irbesartan in chronic aortic coarctated rats

Christian Höcht1, Javier A W Opezzo, Carlos A Taira

  • 1Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina. chocht@ffyb.uba.ar

Pharmacology
|November 27, 2004
PubMed

Insights

Chronic aortic coarctation in rats did not alter irbesartan pharmacokinetics but enhanced its central nervous system distribution. This suggests a hypothalamic mechanism contributing to irbesartan's greater antihypertensive effect in coarctated animals.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology
  • Neuroscience

Background:

  • Hypertension is a complex condition with multifactorial origins.
  • The renin-angiotensin system plays a crucial role in blood pressure regulation.
  • Central nervous system mechanisms, particularly within the hypothalamus, are implicated in hypertension management.

Purpose of the Study:

  • To investigate the central and plasma pharmacokinetics of irbesartan (IRB) in rats with chronic aortic coarctation (ACo) versus sham-operated (SO) controls.
  • To evaluate the potential antihypertensive effect of irbesartan within the hypothalamus.
  • To explore the role of central mechanisms in irbesartan's hypotensive action in a hypertensive model.

Main Methods:

  • Microdialysis technique was employed to measure irbesartan concentrations in plasma and the anterior hypothalamus.
  • Wistar rats underwent either aortic coarctation (ACo) or sham-operation (SO) and were studied at a chronic hypertensive stage.
  • Systemic and direct hypothalamic perfusion of irbesartan were performed to assess its effects on heart rate and mean arterial pressure.

Main Results:

  • Systemic irbesartan administration caused a greater reduction in mean arterial pressure in ACo rats compared to SO rats.
  • Plasma pharmacokinetics of irbesartan were similar between ACo and SO groups.
  • Hypothalamic distribution of irbesartan was significantly higher in ACo rats than in SO rats.
  • Direct hypothalamic perfusion of irbesartan induced an antihypertensive effect specifically in ACo rats.

Conclusions:

  • Chronic aortic coarctation does not alter irbesartan plasma pharmacokinetics but enhances its distribution into the central nervous system.
  • The augmented hypotensive effect of irbesartan in coarctated rats suggests the involvement of central mechanisms, potentially via the anterior hypothalamic angiotensin system.
  • AT1 receptors in the hypothalamus may play a role in maintaining the hypertensive state in chronic aortic coarctation.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...